Retrieve available abstracts of 7 articles: HTML format
Single Articles
November 2024
MA B, Kamle S, Sadanaga T, Lee CM, et al Chitinase 3-like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune
Responses by Regulating CD47-SIRPalpha- and CD24-Siglec10-Mediated Phagocytosis.
J Immunol. 2024;213:1279-1291. PubMedAbstract available
October 2024
OZAKINCI H, Song X, Nazario GS, Lila T, et al Rapid Autopsy to Define Dendritic Cell Spatial Distribution and T Cell
Association in Lung Adenocarcinoma.
J Immunol. 2024;213:1033-1041. PubMedAbstract available
September 2024
DIAMANTOPOULOS N, Li J, Bouchard A, Joumier L, et al ICOS-expressing Regulatory T Cells Influence the Composition of Antitumor CTL
Populations.
J Immunol. 2024;213:753-762. PubMedAbstract available
July 2024
SHANAHAN SL, Kunder N, Inaku C, Hagan NB, et al Longitudinal Intravascular Antibody Labeling Identified Regulatory T Cell
Recruitment as a Therapeutic Target in a Mouse Model of Lung Cancer.
J Immunol. 2024 Jul 31:ji2400268. doi: 10.4049/jimmunol.2400268. PubMedAbstract available
May 2024
SAXENA R, Bushey RT, Campa MJ, Gottlin EB, et al Promotion of an Antitumor Immune Program by a Tumor-specific,
Complement-activating Antibody.
J Immunol. 2024;212:1589-1601. PubMedAbstract available
January 2024
TOYOFUKU T, Ishikawa T, Nojima S, Kumanogoh A, et al Efficacy against Lung Cancer Is Augmented by Combining Aberrantly N-Glycosylated
T Cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1
Neighbor.
J Immunol. 2024 Jan 12:ji2300618. doi: 10.4049/jimmunol.2300618. PubMedAbstract available
October 2023
RAV E, Maegawa S, Gopalakrishnan V, Gordon N, et al Overview of CD70 as a Potential Therapeutic Target for Osteosarcoma.
J Immunol. 2023;211:1067-1072. PubMedAbstract available